Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Stem cells improve nerve repair by enhancing blood vessel growth.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Some drugs used to treat inflammation may cause hair loss.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Both microneedling and injections are equally effective for treating alopecia areata.